# V1 Empirics Check — openai/gpt-oss-120b (Variant A)

**Model:** openai/gpt-oss-120b
**Variant:** A
**Date:** 2026-03-31T14:41:35.754176

---

**Referee Report**

---

### 1. Idea Fidelity  

The manuscript follows the original manifest closely. It exploits variation in state municipal‑broadband preemption laws (22 treated states, 28 controls) to identify the effect of those laws on Medicare tele‑health utilization during COVID‑19. All elements of the proposed design are present:  

* **Identification strategy** – staggered‑difference‑in‑differences (DiD) with a post‑COVID “treatment” period, a triple‑difference exploiting the rural/urban breakdown, and an event‑study presentation.  
* **Data sources** – CMS Medicare Tele‑health Trends (state‑by‑quarter utilization), FCC Form‑477 (broadband provision), ACS B28002 (subscription rates), and Medicaid‑expansion indicators, exactly as listed in the manifest.  
* **Research question** – whether pre‑COVID preemption laws reduced tele‑health uptake, interpreted as a “restriction trap.”  

The paper does **not** make use of the FCC Form‑477 data directly in the baseline regressions; the only place it appears is a brief discussion of the mechanism. The manifest suggested that the FCC data could be used to construct a more granular “broadband supply” measure (e.g., number of providers per census block) and perhaps to control for post‑COVID broadband deployments. While the authors include a pre‑COVID broadband‑subscription rate as a control, they miss the opportunity to exploit the richer FCC data for robustness or to test the mechanism more directly. Apart from this, the paper stays true to the original idea.  

---

### 2. Summary  

The paper estimates that state‑level municipal‑broadband preemption laws, enacted well before the pandemic, cut Medicare tele‑health utilization by about 2.4 percentage points (≈14 % of the control mean) over 2020‑2025, with the largest gap (‑6.4 pp) in the acute Q2‑2020 wave. The results are obtained via a two‑way fixed‑effects DiD, supported by event‑study and triple‑difference analyses, and appear robust to several specification checks.  

---

### 3. Essential Points  

| # | Issue | Why it matters | Recommended fix |
|---|-------|----------------|-----------------|
| **1** | **Parallel‑trends plausibility** – The pre‑COVID tele‑health series starts in 2020 Q1, giving only one pre‑treatment observation. The authors argue that “tele‑health was essentially zero” and therefore pre‑trends cannot exist, but this claim is not empirically verified. | Without a formal pre‑trend test the DiD identification is vulnerable to any differential shock coinciding with the pandemic (e.g., state‑level health‑policy changes, Medicaid‑tele‑health expansions) that also correlates with preemption status. | Use alternative pre‑COVID outcome(s) that are observed earlier and plausibly linked to broadband, such as 2018–2019 broadband‑subscription rates, video‑call usage from the American Time Use Survey, or even “in‑person outpatient visits per 1,000 Medicare beneficiaries.” Show that treated and control states follow similar trends in these proxies. |
| **2** | **Mechanism – reliance on broadband supply** – The paper’s central narrative is that preemption reduced broadband capacity, which in turn lowered tele‑health use. Yet the empirical strategy does not directly test this channel; the only supply‑side variable is a pre‑COVID broadband‑subscription rate entered as a control. | If the effect operates through a different channel (e.g., state regulatory attitudes toward tele‑health, differential COVID‑case rates), the “restriction trap” story is weakened. | Exploit the FCC Form‑477 data to construct a post‑COVID “broadband‑availability” variable (e.g., percent of census blocks with ≥25 Mbps service). Include it and its interaction with preemption in the DiD. Conduct a mediation analysis: (i) preemption → broadband availability; (ii) broadband availability → tele‑health. Also, add state‑level COVID case or death rates as controls to rule out health‑shock confounding. |
| **3** | **Rural‑urban heterogeneity** – The triple‑difference shows an insignificant rural interaction, contrary to the hypothesized stronger effect in rural areas. The authors provide a narrative explanation but do not explore alternative specifications. | If the effect truly differs by geography, the policy implication (that preemption hurts all residents) changes. | Re‑estimate the DiD separately for rural and urban subsamples, allowing for different baseline trends. Test for differential pre‑trend violations in each subsample. Consider interacting preemption with a continuous measure of broadband penetration (or the FCC “availability” metric) rather than a binary rural indicator. |

If any of these three points cannot be satisfactorily addressed, the paper should be **rejected** because the causal claim remains unsupported.

---

### 4. Suggestions  

Below are constructive recommendations that, while not strictly required for acceptance, would considerably strengthen the manuscript, improve its readability, and increase its appeal to the AER‑Insights audience.

#### A. Strengthen Identification  

1. **Pre‑trend validation with alternative outcomes** – As noted, use earlier‑available variables (e.g., 2017‑2019 broadband subscription rates, Google Mobility data for health‑service visits, or county‑level tele‑health use from other payers if accessible). Plot treated vs. control trends and run placebo DiD with a “fake” post‑COVID date (e.g., 2019 Q3).  

2. **Event‑study presentation** – The current Table 2 only lists the reference quarter; a full figure with confidence bands (e.g., using the `coefplot` or `ggplot2` style) would let readers see the dynamics and assess any pre‑trend “wiggle.” Include the 95 % confidence interval and a line at zero.  

3. **Staggered treatment timing** – Although all preemptions were in place by 2020, they were enacted at different years. Recent literature (e.g., Sun & Abraham 2021; de Chaisemartin & D’Haultfœuille 2020) shows that two‑way FE can produce biased ATT estimates in staggered settings when treatment effects are heterogeneous. The authors should either (i) verify that the “all‑treated‑by‑2020” design satisfies the “no variation in timing” condition, or (ii) re‑estimate using an aggregation‑compatible estimator (e.g., `eventstudy` with the `did` package, or the `group‑time` ATT estimator).  

#### B. Deepen the Mechanism Analysis  

1. **Broadband supply index** – Construct a state‑quarter variable from FCC Form‑477: share of census blocks with at least 25 Mbps downlink. Plot this over time for treated vs. control states. Include it as a mediator in a two‑stage least squares (2SLS) where preemption predicts broadband availability, which in turn predicts tele‑health.  

2. **Policy heterogeneity** – Not all preemption statutes are identical (some ban only new construction, others require costly referenda). Code a “stringency index” (e.g., 0 = no restriction, 1 = ban on any municipal network, 2 = heavy procedural hurdles). Test whether more stringent laws generate larger tele‑health gaps.  

3. **COVID severity controls** – Add state‑level cumulative COVID cases and deaths (per 100,000) as time‑varying covariates. If preempted states also had milder outbreaks, the observed tele‑health gap could be partially driven by lower demand rather than supply constraints.  

#### C. Robustness Enhancements  

1. **Alternative clustering** – With only 50 clusters, state‑level clustering can be noisy. Report wild‑cluster bootstrap‑by–state (already done) and also the `CR2` adjustment (Cameron, Gelbach, Miller 2008).  

2. **Placebo outcomes** – Apply the same DiD to outcomes that should be unaffected by broadband (e.g., Medicare claims for non‑tele‑health services, or rates of cataract surgeries). Null effects would bolster credibility.  

3. **Sensitivity to control set** – The baseline controls are limited to broadband subscription, income, college, and Medicaid expansion. Test inclusion of other variables (e.g., political partisanship, health‑care provider density) to assure results are not driven by omitted‑variable bias.  

#### D. Presentation & Transparency  

1. **Data & code availability** – The manuscript mentions a GitHub repository, but the link points to a generic project page. Provide a direct link to the exact commit that contains the cleaned data files (or a reproducible script to download the CMS, FCC, ACS data) and the Stata/R/Python code used for estimations.  

2. **Descriptive statistics** – Table 1 could be expanded to show pre‑COVID broadband provision (FCC) and COVID case rates, to illustrate baseline comparability.  

3. **Interpretation of effect size** – The paper states a 2.4 pp reduction equals a 14 % drop relative to the control mean. It would be helpful to translate this into a health‑outcome metric (e.g., number of missed visits, potential excess mortality) using existing literature on tele‑health effectiveness. Even a back‑of‑the‑envelope calculation would make the welfare implication more tangible.  

4. **Minor edits** –  
   * Consistently refer to “preemption” (not “pre-empt”) to avoid confusion.  
   * In the event‑study regression (Equation 2) define the omitted quarter explicitly.  
   * Clarify that “post” starts in 2020 Q2 (the first quarter with expanded Medicare tele‑health coverage).  

#### E. Extensions (optional, for future work)  

* **Heterogeneous impacts by demographic groups** – If the CMS data can be disaggregated by age, race, or chronic‑condition status, the authors could examine whether the preemption gap is larger for vulnerable subpopulations.  
* **Long‑run health outcomes** – Linking to mortality or hospitalization data would allow the authors to assess whether the tele‑health gap translated into measurable health differences.  

---

### Overall Assessment  

The paper tackles a novel and policy‑relevant question, leveraging a clean ex‑ante variation in municipal broadband preemption laws to study COVID‑era tele‑health adoption. The data are high‑quality and the baseline results are suggestive. However, the identification strategy hinges on a fragile parallel‑trends assumption that cannot be verified with the current outcome series, and the central “restriction trap” mechanism remains under‑tested. Addressing the three essential points—pre‑trend evidence, direct measurement of broadband supply, and a more nuanced exploration of rural‑urban heterogeneity—should be a prerequisite for publication.  

If the authors can supply convincing placebo tests, a robust mediation analysis using FCC data, and alternative DiD estimators that respect staggered adoption, I would be inclined to recommend **acceptance with major revisions**. Otherwise, the paper should be **rejected**.
